Next Generation Sequencing Market Research Reports & Industry Analysis
The next generation sequencing (NGS) industry is altering our understanding of genetics and leading to advancements in healthcare, agriculture, and other critical areas. NGS market growth is being driven by decreasing cost, rapid turnaround times, and the rise of high throughput sequencing, with the power to facilitate large-scale population studies, microbiome research, and cancer genomics. MarketResearch.com provides a collection of next generation sequencing industry reports to help you navigate this evolving landscape and gain in-depth insights.
Next Generation Sequencing Market Analysis
- Drawing on extensive primary and secondary research, our reports provide expert market analysis, company profiles, and strategic recommendations.
- We explain how the next generation sequencing market is evolving, and how you can ensure you are at the forefront of the market.
- In addition, our research pinpoints the most lucrative areas of the market, so you can capitalize on them at the right time.
A Research Partner You Can Trust
With more than two decades of experience in the field, MarketResearch.com has long served a range of clients including leading investment banks, management consulting firms, and Fortune 500 multinational corporations. We collect reports from hundreds of leading firms to create a convenient source of insights accessible through a single platform. Each step of the way, our dedicated research specialists are available to offer expert guidance and recommendations.
Next Generation Sequencing Industry Research & Market Reports
-
Liquid Biopsy Market (4th Edition), 2018-2022 (Historical Trends) and 2023-2035 (Forecasted Estimates): Distribution by Application (Early Cancer Diagnosis, Patient Monitoring, Treatment Selection, Recurrence Monitoring and Others), Target Disease Indication (Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Lung Cancer, Prostate Cancer and Others), Type of Circulating Biomarker (Cell Free DNA, Cell Free RNA, Circulating Tumor DNA, Extracellular Vesicles and Others Circulating Biomarkers), Type of Sample (Blood / Plasma and Others), End users (Hospitals, Research Institutes and Others), Stage of Development (Launched and Under Development), Type of Product (Assay kits, Devices, Software/ Algorithms and others), Type of Technique (Polymerase Chain Reaction, Next Generation Sequencing and Others), Application Area ( Clinical use, Research use only) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecast
... Gastric Cancer, Lung Cancer, Prostate Cancer and Others), Type of Circulating Biomarker (Cell Free DNA, Cell Free RNA, Circulating Tumor DNA, Extracellular Vesicles and Others Circulating Biomarkers), Type of Sample (Blood / Plasma and Others), ... Read More
-
Single-cell Analysis: Technology Growth Opportunities
... better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provided through this method of analysis gives in-depth insight into gene expression and other factors determining a pathological ... Read More
-
Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
... example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost. While older, PCR continues ... Read More
-
Clinical Oncology Next Generation Sequencing Global Market Report 2024
... By End User: Hospital Laboratories; Clinical Research Organizations; Diagnostic laboratoriesCovering: Thermo Fisher Scientific; Oxford Nanopore Technologies Ltd.; QIAGEN N.V.; Myriad Genetics Inc.; Illumina Inc. Clinical Oncology Next Generation Sequencing Global Market Report 2024 from The ... Read More
-
Pharmacogenomics Global Market Opportunities And Strategies To 2032
... By End User: Hospitals and Clinics; Research Institutions; Academic InstitutesCovering: Illumina Inc.; Eurofins Scientific; Myriad Genetics Inc.; PerkinElmer Inc.; Centogene N.V. Pharmacogenomics Global Market Opportunities And Strategies To 2032 from The Business Research Company provides ... Read More
-
Global Microbial Single-Cell Sequencing Market Growth (Status and Outlook) 2023-2029
... demand in downstream market, the Microbial Single-Cell Sequencing is forecast to a readjusted size of US$ 8122.1 million by 2029 with a CAGR of 17.5% during review period. The research report highlights the growth potential ... Read More
-
Global Microbial Single-Cell Sequencing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... million in 2022 and is forecast to a readjusted size of USD 7875.4 million by 2029 with a CAGR of 16.2% during review period. Microbial single-cell sequencing is a highly refined sequencing technology used to ... Read More
-
Global Microbial Single-Cell Sequencing Supply, Demand and Key Producers, 2023-2029
... the forecast period (2023-2029). Microbial single-cell sequencing is a highly refined sequencing technology used to study the genome, transcriptome, metabolome and other molecular characteristics of individual microbial cells in the field of microorganisms. Its development ... Read More
-
Immune Repertoire Sequencing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Recent advancements in next-generation sequencing (NGS) technology have paved the way for groundbreaking discoveries in the field of immune repertoire sequencing. This cutting-edge technique, which probes the complementarity-determining regions of B-cell receptors (BCRs) and T-cell ... Read More
-
High End Cellomics Market, By Product Type (Instruments, Reagents and Consumables, and Software & Services), By Application (Drug discovery, Cancer Research, Neuroscience, Stem Cell Research and Regenerative Medicine, Personalized Medicine, and Others), By Technology (Microscopy, Flow Cytometry, Single-cell Genomics, Mass Spectrometry, Next Generation Sequencing, and Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Flow Cytometry, Single-cell Genomics, Mass Spectrometry, Next Generation Sequencing, and Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia ... Read More
-
Single Cell Analysis Global Market Opportunities And Strategies To 2032
... Pharmaceutical Companies; Hospital; Diagnostic Laboratories4)By Technique: Flow Cytometry; Next Generation Sequencing; Polymerase Chain Reaction (PCR); Microscopy; Mass Spectrometry5)By End User Workflow: Single-Cell Isolation; Library Preparation; Downstream Analysis; Data AnalysisCovering: The Becton, Dickinson, and Company; Merck ... Read More
-
Neurogenetic Testing Market Forecasts to 2030 – Global Analysis By Type (Microarray Analysis, Whole-Exome Sequencing (WES), Multiplex Ligation Dependent Probe Amplification (MLPA), Polymerase Chain Reaction (PCR) Tests and Other Types), By End User (Hospitals, Specialty Clinics, Research Institutes, Diagnostics Laboratories and Other End Users) and By Geography
... Clinics, Research Institutes, Diagnostics Laboratories and Other End Users) and By Geography According to Stratistics MRC, the Global Neurogenetic Testing Market is accounted for $616.7 million in 2023 and is expected to reach $1372.1 million ... Read More
-
Cell Biology Market Forecasts to 2030 – Global Analysis By Product (Microscopy and Imaging, Cell Analysis Instruments, Molecular Biology Kits, Cell-based Assays and Other Products), Technology (Next-Generation Sequencing (NGS), Gene Editing Technologies, Bioinformatics and Computational Tools, Cell Culture and Tissue Engineering, Proteomics and Protein Analysis and Other Technologies), Application, End User and By Geography
... Tools, Cell Culture and Tissue Engineering, Proteomics and Protein Analysis and Other Technologies), Application, End User and By Geography According to Stratistics MRC, the Global Cell Biology Market is accounted for $20.6 billion in 2023 ... Read More
-
In Vitro Diagnostic (IVD) Trends and Market Update: November 2023
... gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for ... Read More
-
mRNA Vaccines Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Extensive research has been conducted on mRNA vaccines as potential ... Read More
-
Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) & Region - Global Forecast to 2028
... The HMI market is estimated to be worth USD 5.2 billion in 2023 and is projected to reach USD 7.7 billion by 2028 at a CAGR of 8.2% during the forecast period. The HMI market ... Read More
-
mRNA-1010 Emerging Drug Insight and Market Forecast − 2032
... of the mRNA-1010 for seasonal influenza in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
DNA Synthesizer Market, By Product Type (Benchtop DNA Synthesizers, Automated DNA Synthesizers), By Application (Gene Synthesis, Oligonucleotide Synthesis, Next-Generation Sequencing (NGS) Library Preparation, Drug Development, Others (DNA labeling, aptamer synthesis, synthetic biology)), By Synthesis Scale (Small-Scale DNA Synthesis, Medium-Scale DNA Synthesis, Large-Scale DNA Synthesis), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Forensic Laboratories, Others (government organizations, diagnostic laboratories)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (Small-Scale DNA Synthesis, Medium-Scale DNA Synthesis, Large-Scale DNA Synthesis), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Forensic Laboratories, Others (government organizations, diagnostic laboratories)), By Geography (North America, ... Read More
-
India Emerging Infectious Disease Diagnostics Market: Focus on Epidemiology, Application, Technology, Type of Infection, Disease Type, and End User - Analysis and Forecast, 2023-2033
... disease diagnostics market is projected to experience substantial growth over the forecast period 2023-2033. Moreover, the market value for 2022 was estimated to be $339.1 million and is expected to reach $982.7 million by 2033, ... Read More
-
Personalized Genomics Market, By Test Type (Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Others), By Technology (PCR-based Tests, Microarray-based Tests, Sequencing-based Tests, Others), By Application (Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition & Health Lifestyle, Others), By End User (Hospitals & Clinics, Research Centers, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... & Health Lifestyle, Others), By End User (Hospitals & Clinics, Research Centers, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Personalized genomics is ... Read More
-
Protein Sequencing Market, By Technology (Edman Degradation, Mass Spectrometry, Others), By Product (Instruments, Reagents, Kits & Consumables, Software & Services), By Application (Academic Research, Clinical Diagnosis, Biopharmaceuticals, Others), By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... & Research Institutes, Contract Research Organizations), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Protein sequencing is a crucial technique used in the field of biochemistry and molecular biology to ... Read More
-
Global Clinical Whole Exome Sequencing (WES) Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. Clinical Whole Exome Sequencing (WES) is a comprehensive genetic ... Read More
-
Forensic Technology Market - By Technology (Spectroscopy, Next Generation Sequencing (NGS)), Component (Product, Service), Sample Type (Blood, Skin), Application (Judicial & Law Enforcement, Pharmacogenetics), Global Forecast, 2023-2032
... than 10.3% CAGR from 2023 to 2032. Technological advancements, such as AI and machine learning, have played a pivotal role in enhancing the efficiency and accuracy of forensic investigations. In October 2023, Detego Global introduced ... Read More
-
Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... the market to reach US$ 48.9 Billion by 2028, exhibiting a growth rate (CAGR) of 18.5% during 2023-2028. Next-generation sequencing (NGS) is a parallel sequencing technology that determines the sequence of nucleotides in a section ... Read More
-
Short-Read Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030
... & clinic, and pharmaceutical & biotechnology markets. The global short-read sequencing market is expected to reach an estimated $17.1 billion by 2030 with a CAGR of 18.9% from 2024 to 2030. The major drivers for ... Read More
Research Assistance
